Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

First-of-its-kind computer model simulates a clinical trial evaluating two Alzheimer’s drugs

An estimated 6.2 million Americans ages 65 and older are living with Alzheimer's disease. The national Alzheimer's Association predicts that number to grow to 13.8 million by 2060, barring the development of medical breakthroughs that would prevent, slow or cure the debilitating disease.

2 Nov 2022

Researchers corroborate the importance of exercise for cognitive function

Accumulating evidence finds that exercise can improve brain function and delay or prevent the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

2 Nov 2022

Memory: a revolutionary treatment for mental health disorders and neurodegeneration?

In this interview, we speak to Dr. Steve Ramirez about his latest neuroscience research that investigated the power of our memories.

2 Nov 2022

Hurricane Ian’s deadly impact on Florida seniors exposes need for new preparation strategies

All kinds of natural disasters — hurricanes, tornadoes, floods, wildfires, dangerous heat waves — pose substantial risks to older adults. Yet, not enough seniors prepare for these events in advance, and efforts to encourage them to do so have been largely unsuccessful.

2 Nov 2022

Researchers unravel how the brain chemical dopamine relates to schizophrenia

Researchers at the Lieber Institute for Brain Development (LIBD) believe they have solved a riddle that has challenged scientists for more than 70 years: how the brain chemical dopamine relates to schizophrenia, the often-devastating brain disorder characterized by delusional thinking, hallucinations and other forms of psychosis.

1 Nov 2022

People who had COVID-19 are more vulnerable to developing neurological symptoms

Research led by The University of Queensland has found COVID-19 activates the same inflammatory response in the brain as Parkinson's disease.

1 Nov 2022

COVID-19 presents caregivers with unique challenges not seen in other patients

Roughly 21% of hospitalized COVID-19 patients at the height of the pandemic required an intensive care stay and the bulk were cared for by family upon discharge.

31 Oct 2022

Scientists reveal anti-inflammatory molecules that play an important role in aging

Aging involves complicated plot twists and a large cast of characters: inflammation, stress, metabolism changes, and many others. Now, a team of Salk Institute and UC San Diego scientists reveal another factor implicated in the aging process-;a class of lipids called SGDGs (3-sulfogalactosyl diacylglycerols) that decline in the brain with age and may have anti-inflammatory effects.

31 Oct 2022

Appel Alzheimer's Disease Research Institute Symposium reveals new developments in dementia research

The 10th annual Appel Alzheimer's Disease Research Institute Symposium brought fascinating reports of progress in understanding Alzheimer's and related neurodegenerative diseases.

28 Oct 2022

Study provides new insights into genetic form of frontotemporal dementia

Dementia encompasses a range of neurodegenerative conditions that lead to memory loss and cognitive deficiencies and affect some 55 million people worldwide.

28 Oct 2022

Huntington's disease impairs autophagy in older patients

Huntington's disease, a fatal, inherited neurodegenerative condition, is caused by a genetic error present at birth, though its symptoms often don't begin until middle adulthood.

28 Oct 2022

Proof-of-principle study: Novel tool advances potential way to deliver gene therapy

Johns Hopkins Medicine researchers say they have successfully used a cell's natural process for making proteins to "slide" genetic instructions into a cell and produce critical proteins missing from those cells.

28 Oct 2022

New discovery may change the textbook model of GPCR-mediated signaling

Researchers at University of California San Diego have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs.

27 Oct 2022

Strongest evidence to date that lowering blood pressure in later life can cut dementia risk

A global study of over 28,000 people has provided the strongest evidence to date that lowering blood pressure in later life can cut the risk of dementia.

26 Oct 2022

Higher exposure to particulate matter may be associated with increased dementia risk

Higher exposure to a certain type of traffic-related air pollution called particulate matter may be linked to an increased risk of dementia, according to a meta-analysis published in the October 26, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

26 Oct 2022

Subarachnoid hemorrhage incidence is higher and increasing in Black patients, study says

Rates of one type of stroke called subarachnoid hemorrhage have increased in older people and men in recent years, and such strokes occur in Black people at a disproportionately higher rate compared to people of other races and ethnicities, according to a study published in the October 26, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

26 Oct 2022

$10.3 million NIH grant to support URI neuroscientist's research on retinal scanning to detect early-stage Alzheimer’s

Jessica Alber, assistant professor of biomedical and pharmaceutical sciences at the George & Anne Ryan Institute for Neuroscience at the University of Rhode Island, is looking to change the way doctors diagnose Alzheimer's disease, a change that could raise new possibilities for treatment.

26 Oct 2022

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

First-of-its-kind computer model simulates a clinical trial evaluating two Alzheimer’s drugs

Researchers corroborate the importance of exercise for cognitive function

Memory: a revolutionary treatment for mental health disorders and neurodegeneration?

Hurricane Ian’s deadly impact on Florida seniors exposes need for new preparation strategies

Researchers unravel how the brain chemical dopamine relates to schizophrenia

People who had COVID-19 are more vulnerable to developing neurological symptoms

COVID-19 presents caregivers with unique challenges not seen in other patients

Scientists reveal anti-inflammatory molecules that play an important role in aging

Appel Alzheimer's Disease Research Institute Symposium reveals new developments in dementia research

Study provides new insights into genetic form of frontotemporal dementia

Huntington's disease impairs autophagy in older patients

Proof-of-principle study: Novel tool advances potential way to deliver gene therapy

New discovery may change the textbook model of GPCR-mediated signaling

Strongest evidence to date that lowering blood pressure in later life can cut dementia risk

Higher exposure to particulate matter may be associated with increased dementia risk

Subarachnoid hemorrhage incidence is higher and increasing in Black patients, study says

$10.3 million NIH grant to support URI neuroscientist's research on retinal scanning to detect early-stage Alzheimer’s

Exploring new therapeutic targets and biomarkers for neurodegenerative disorders

Discovery could affect the search for new Alzheimer's drugs

Study estimates the burden of dementia among older adults in the U.S.

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in